Includes results from additional continuous glucose monitoring (CGM)-based outcomes which demonstrate significant and ...

Frequent CGM use ties to bigger A1c drops in type 2 diabetes, even across GLP-1, SGLT2, and insulin regimens. In this episode ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

Patients who undergo stepwise escalation often reach treatment failure more often.” He noted that combination therapy may be ...

Incretin class drugs are associated with the most favorable CGM-based outcomes among glucose-lowering medications for type 2 ...

Laparoscopic one anastomosis gastric bypass achieves sustained diabetes remission in most patients with type 2 diabetes and ...

Recent updates to the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) guidelines have focused on the need for more intensive therapy in patients with type 2 ...

After the initiation of an AID system, glycemic control improved and the effect persisted throughout the study period. (HealthDay News) — Initiation of an automated insulin delivery (AID) system ...

Relaxed glycemic control targets were associated with an increased risk for skin, bone, and soft tissue infections among older adults with type 2 diabetes. Older adults with type 2 diabetes and ...

GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, ...

Diabetes prevalence in U.S. adults over the past decade has remained stable, with a small non-significant increase. HbA1c and rates of glycemic control significantly worsened from 2017-2020 to ...

The risk for poor glycemic control in patients with type 2 diabetes can be predicted with confidence by using machine learning methods, a new study finds. The most important factors predicting ...